- Home
- VYNE vs SMSI Comparison
VYNE vs SMSI Comparison
Compare VYNE & SMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- SMSI
- Stock Information
- Founded
- VYNE 2003
- SMSI 1982
- Country
- VYNE United States
- SMSI United States
- Employees
- VYNE N/A
- SMSI N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- SMSI Computer Software: Prepackaged Software
- Sector
- VYNE Health Care
- SMSI Technology
- Exchange
- VYNE Nasdaq
- SMSI Nasdaq
- Market Cap
- VYNE 16.0M
- SMSI 15.9M
- IPO Year
- VYNE 2018
- SMSI 1995
- Fundamental
- Price
- VYNE $1.45
- SMSI $0.89
- Analyst Decision
- VYNE Strong Buy
- SMSI Strong Buy
- Analyst Count
- VYNE 2
- SMSI 1
- Target Price
- VYNE $6.25
- SMSI $5.00
- AVG Volume (30 Days)
- VYNE 1.3M
- SMSI 99.9K
- Earning Date
- VYNE 08-13-2025
- SMSI 07-31-2025
- Dividend Yield
- VYNE N/A
- SMSI N/A
- EPS Growth
- VYNE N/A
- SMSI N/A
- EPS
- VYNE N/A
- SMSI N/A
- Revenue
- VYNE $605,000.00
- SMSI $19,378,000.00
- Revenue This Year
- VYNE $42.51
- SMSI $10.12
- Revenue Next Year
- VYNE N/A
- SMSI $63.12
- P/E Ratio
- VYNE N/A
- SMSI N/A
- Revenue Growth
- VYNE 43.03
- SMSI N/A
- 52 Week Low
- VYNE $0.85
- SMSI $0.52
- 52 Week High
- VYNE $4.30
- SMSI $2.57
- Technical
- Relative Strength Index (RSI)
- VYNE 56.76
- SMSI 51.78
- Support Level
- VYNE $0.85
- SMSI $0.84
- Resistance Level
- VYNE $1.96
- SMSI $0.98
- Average True Range (ATR)
- VYNE 0.20
- SMSI 0.06
- MACD
- VYNE 0.07
- SMSI -0.00
- Stochastic Oscillator
- VYNE 51.80
- SMSI 43.75
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.